Home
Conditions
Mild Cognitive Impairment

Clinical trial condition

Mild Cognitive Impairment

Explore clinical trials studying Mild Cognitive Impairment. Study availability and eligibility vary by location and protocol.

915 public trials 176 recruiting studies

Refine in advanced search Browse all conditions

Mild Cognitive Impairment trial results

Completed

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

NCT00934375

Conditions: Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +2 more
Locations: Neurology Neurodiagnostic Lab, LLC Alabaster, Alabama, United States

Pivotal Research Centers Peoria, Arizona, United States

Sun Health Research Institute Sun City, Arizona, United States

Northwest Neurospecialists, PLLC Tucson, Arizona, United States

View all 49 locations

View Trial Details

Completed

Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease

NCT01661673

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
Locations: Glendale Adventist Medical Center Glendale, California, United States

View Trial Details

Completed

SMART: Somatotrophics, Memory, and Aging Research Trial

NCT00257712

Conditions: Aging, Alzheimer Disease, Brain Diseases, +10 more
Locations: University of Washington Seattle, Washington, United States

View Trial Details

Completed

Impact of a Memory Group for Older Adults Reporting Memory Difficulties

NCT01998711

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
Locations: Caulfield General Medical Centre Melbourne, Victoria, Australia

View Trial Details

Completed

Prospective Research in Memory Clinics (PRIME)

NCT00297271

Conditions: Brain Diseases, Central Nervous System Diseases, Cognition Disorders, +6 more
Locations: Chermside, Australia

Fremantle, Australia

Geelong, Australia

Heidelberg, Australia

View Trial Details

Completed

A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

NCT01662882

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
Locations: Research Site Kobe, Japan

Research Site Tokyo, Japan

View Trial Details

Completed

Efficacy Study of Cognitive Intervention in Amnestic Mild Cognitive Impairment

NCT01358955

Conditions: Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +2 more
Locations: Korea University Medical College Ansan, South Korea

Soonchunhyang University Hospital Bucheon-si, South Korea

Bucheon St. Mary's Hospital, the Catholic University of Korea Bucheon-si, South Korea

Donga University Hospital Busan, South Korea

View all 18 locations

View Trial Details

Completed

Impact of Transcranial Direct Current Stimulation on Language Functions in Mild Cognitive Impairment

NCT01771211

Conditions: Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +2 more
Locations: Charite University Medicine, Department of Neurology Berlin, State of Berlin, Germany

View Trial Details

Completed

NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease

NCT01600469

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
Locations: Kaohsiung Chang Gung Memorial Hospital Kaohsiung, Taiwan

View Trial Details

Completed

NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)

NCT01370954

Conditions: Alzheimer Disease, Alzheimer's Disease, Arterial Occlusive Diseases, +26 more
Locations: Falls Neurology and Memory Center Hickory, North Carolina, United States

View Trial Details

Mild Cognitive Impairment

Mild Cognitive Impairment trial results

Related conditions